ID: ALA182364

Max Phase: Preclinical

Molecular Formula: C14H21N5

Molecular Weight: 259.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc2[nH]c(CN3CCNCCNCC3)nc2c1

Standard InChI:  InChI=1S/C14H21N5/c1-2-4-13-12(3-1)17-14(18-13)11-19-9-7-15-5-6-16-8-10-19/h1-4,15-16H,5-11H2,(H,17,18)

Standard InChI Key:  JPSIAWFSEUYISV-UHFFFAOYSA-N

Associated Targets(Human)

Cell line 371 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 259.36Molecular Weight (Monoisotopic): 259.1797AlogP: 0.56#Rotatable Bonds: 2
Polar Surface Area: 55.98Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.49CX Basic pKa: 9.87CX LogP: 0.23CX LogD: -2.26
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.74Np Likeness Score: -1.52

References

1. Ji HF, Zhang HY..  (2005)  A new strategy to combat Alzheimer's disease. Combining radical-scavenging potential with metal-protein-attenuating ability in one molecule.,  15  (1): [PMID:15582403] [10.1016/j.bmcl.2004.10.047]

Source